Bacteriophages 2015: Meeting Announcement


Tuesday, 27 January 2015 09:00 – Thursday, 29 January 2015 17:00


This event will discuss the many roles of bacteriophages, ranging from fundamental biological research to their use in medical and industrial biotechnologies.  Topics will include  uses of phages for therapeutics, food manufacture, delivery vectors, drivers of microbiota structure reporters of microbiome diversity, and their  role on the environment 

This event  has CPD accreditation and an open oral and poster session.  Abstracts can be submitted on any subject related to Bacteriophages

The Deadline for abstract submissions for oral presentation is Oct10th 2014
Abstracts for poster presentation only can be submitted up to two weeks before the event
You can download the instructions for authors at

Hashtag: #Phage2015

Talks include
European Implementation of Bacteriophage Therapy: Impact of Medicinal Product Legislation on Tailored Hospital Care
Gilbert Verbeken, Queen Astrid Military Hospital, Burn Wound Centre, Brussels, Belgium

Regulation of replication of Shiga toxin-converting bacteriophages
Professor Grzegorz Wegrzyn, Department of Molecular Biology, University of Gdansk, Poland

Bacteriophages for healthy living
Dr Alexander Sulakvelidze, Intralytix, Inc, Baltimore, USA

Phage recombination
Dr Gary Sharples, Fellow of the Wolfson Research Institute for Health and Wellbeing, Visiting Senior Lecturer in the Department of Chemistry, Senior Lecturer in the School of Biological and Biomedical Sciences, Durham University, UK

Talk title to be confirmed
Professor. Dr. Martin J. Loessner, ETH Zurich, Institute of Food, Nutrition and Health, Schmelzbergstrasse 7, Zurich, Switzerland

GMP manufacture of phages for clinical trial
Tony Hitchcock, Technology Director, Cobra Biologics

Overview on Yersinia phages and update on phage therapy initiative in Finland
Professor Mikael Skurnik, Ph.D., Professor of Bacteriology, Haartman Institute, Department of Bacteriology and Immunology, Research Programs Unit, Immunobiology, Helsinki University Central Hospital Laboratory Diagnostics, Finland

Talk title to be confirmed
Dr. Heather E. Allison, University of Liverpool, BioSciences Building, Crown Street, Liverpool, United Kingdom

Talk title to be confirmed
Dr Magdalena Plotka, Department of Microbiology, University of Gdansk, Poland, Department of Microbiology, University of Gdansk, Gdansk, Poland

Leveraging bacteriophages for high speed, enrichment-free environmental monitoring
Dr Michael Koeris, Founder, VP Business Development & Operations, Sample6, Inc, Boston, US

Atomic structure of Bordetella phage BPP1 reveals a new topology of the highly conserved HK97-like fold
Professor Z. Hong Zhou, Ph.D., Electron Imaging Center for Nanomachines (EICN), CNSI and Dept of Microbiology, Immun. & Mol. Genetics, UCLA, Los Angeles, CA, USA

Novel polymerases from marine phages
Dr Bin Zhu, Boston, MA, USA

Phage therapy in a post antibiotic era: The savior of the human race or a pie in the sky
Professor. Robert R. Bragg, Dept. of Microbial, Biochemical & Food Biotechnology, Faculty of Natural and Agricultural Sciences, University of the Free State, Bloemfontein, South Africa

Phage therapy for collibacillosis and salmonellosis for poultry production
Associate Professor. Dr. Sieo Chin Chin, Department of Microbiology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, Selangor Darul Ehsan, Malaysia

Dr Jodi A Lindsay, PhD, St George’s, University of London, London, UK

Modern ideas for combating bacteria
Dr Zuzanna Drulis-Kawa PhD., Institute of Genetics and Microbiology, University of Wroclaw, Poland

Dr Paul CM Fogg, University of York, Department of Biology, Wentworth Way, York, UK

Confirmed Speakers Include

Professor Stephane Evoy, University of Alberta, Canada
Professor Louise Temple, James Madison University, Harrisonburg, Virginia, USA

Latest Euroscicon Tweets

Error: You currently have access to a subset of Twitter API v2 endpoints and limited v1.1 endpoints (e.g. media post, oauth) only. If you need access to this endpoint, you may need a different access level. You can learn more here: